Tamarack Advisers, LP Cerus Corp Transaction History

Tamarack Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$1.5 - $3.07 $1.65 Million - $3.38 Million	-1,100,000 Reduced 62.86%	650,000 $1.05 Million
Q2 2023 Aug 09, 2023	SELL	$1.79 - $2.9 $895,000 - $1.45 Million	-500,000 Reduced 22.22%	1,750,000 $4.31 Million
Q1 2023 May 10, 2023	SELL	$2.65 - $3.81 $662,500 - $952,500	-250,000 Reduced 10.0%	2,250,000 $6.68 Million
Q4 2022 Feb 10, 2023	BUY	$3.38 - $4.22 $253,500 - $316,500	75,000 Added 3.09%	2,500,000 $9.13 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $1.46 Million - $2.48 Million	425,000 Added 21.25%	2,425,000 $8.73 Million
Q2 2022 Aug 16, 2022	BUY	$4.41 - $5.69 $1.54 Million - $1.99 Million	350,000 Added 21.21%	2,000,000 $10.6 Million
Q1 2022 May 11, 2022	BUY	$4.81 - $6.99 $3.13 Million - $4.54 Million	650,000 Added 65.0%	1,650,000 $9.06 Million
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $5.52 Million - $7.34 Million	925,000 Added 1233.33%	1,000,000 $6.81 Million
Q2 2021 Aug 13, 2021	SELL	$5.35 - $6.35 $401,250 - $476,250	-75,000 Reduced 50.0%	75,000 $443,000
Q1 2021 May 12, 2021	BUY	$5.68 - $7.87 $852,000 - $1.18 Million	150,000 New	150,000 $902,000

156

148M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.